News and Events


events

CHEST 2018

Visit Imbio at booth #1210 during the CHEST annual meeting to see how we are helping transform pulmonary care with machine learning and AI image analysis. CHEST takes place October 6-10th in San Antonio, Texas. For more information please visit CHEST.

events

ATS 2018

Visit Imbio at booth #2320 during the American Thoracic Society meeting and try out our latest advances in Lung AI image analysis. ATS takes place May 18-23, 2018 in San Diego, CA. For more information please visit http://ats-conference.org/.

events

STR 2018

Imbio will exhibit at the STR Thoracic Imaging 2018 meeting in Austin, Texas from March 4-7, 2018. For more information please visit http://thoracicrad.org/?portfolio=annual-meeting.

news

TeraRecon launches EnvoyAI distributorship to resell the 35+ algorithms on the EnvoyAI Exchange, initially promoting FDA-cleared Imbio and icometrix solutions

Chicago, IL – November 27, 2017: Advanced Visualization solution provider, TeraRecon (www.terarecon.com) today announced a distribution partnership with EnvoyAI to sell and market the EnvoyAI platform. The platform includes the most content-rich artificial intelligence marketplace, called the En...



news

Imbio and NTT DATA Services Announce Partnership for Lung Analytic Algorithms in the UCA Imaging Platform

NTT DATA Services, formerly Dell Services, today announced its partnership with Imbio, which will provide algorithms for lung analytics. The algorithms are designed to further enhance automated tools to assist radiology in identifying and quantifying disease present in existing and new imaging studi...



news

Imbio and GE Healthcare Collaborate to Enable Lung Density Analysis™ Within GE Health Cloud Ecosystem

Imbio and GE Healthcare to support more personalized CT lung diagnosis with quantifiable clinical insights

MINNEAPOLIS, March 21, 2016 /PRNewswire/ -- Imbio, a leader in fully automated, biomarker-based solutions for quantitative Lung imaging, and GE Healthcare are pleased to announce a collaboration to make Imbio’s Lung Density AnalysisTM, a volumetric imaging solution for Lung CT, one of the first so...



news

Imbio obtains exclusive commercialization rights to Heidelberg University Hospital’s Airway Tree Analysis software

MINNEAPOLIS, Minnesota— Imbio, LLC, a diagnostic medical imaging software company, announced today that the company has exclusively licensed technology for evaluation of the lung airway tree developed by researchers at the Heidelberg University Hospital.

Extracting and labeling the bronchial tre...



news

Imbio Named Finalist for 16th Annual TEKNE Awards

MHTA to honor Minnesota’s top technology companies and individuals at annual awards ceremony

MINNEAPOLIS, Minnesota - The Minnesota High Tech Association (MHTA) has named Imbio as a finalist in the Healthcare – Small & Growing category for the 2015 Tekne Awards, which will be held at the Minneapolis Convention Center on Thursday, Nov. 18. The Tekne Awards honor Minnesota companies and ind...



news

IMBIO’S CT LUNG ANALYSIS SOFTWARE RECEIVES 510(k) CLEARANCE FROM FDA

Image Processing Software Quantifies Extent of Lung Tissue Damage in COPD

MINNEAPOLIS, Minnesota—Imbio, LLC, a medical image processing software company, has received FDA 510(k) clearance for their Lung Density Analysis software application, developed in collaboration with medical researchers at the University of Michigan.

COPD (Chronic Obstructive Pulmonary Disease)...